Cargando…

Autoinflammation and Myelofibrosis: Report of a Case

Detalles Bibliográficos
Autores principales:	Koduri, Prasad R., Shaik, Amina, Vegulada, Durga Rao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2023
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476249/ https://www.ncbi.nlm.nih.gov/pubmed/37519107 http://dx.doi.org/10.4274/tjh.galenos.2023.2023.0064

Ejemplares similares

A novel genomic inversion in Wiskott-Aldrich–associated autoinflammation
por: Brigida, Immacolata, et al.
Publicado: (2016)

Acute lymphoblastic leukemia masquerading as acute myelofibrosis: a report of two cases and literature review
por: Jain, Ankur, et al.
Publicado: (2021)

Spontaneous necroptosis and autoinflammation are blocked by an inhibitory phosphorylation on MLKL during neonatal development
por: Zhu, Xinxin, et al.
Publicado: (2021)

A CDC42 Stop-loss Mutation in a Patient with Relapsing Polychondritis and Autoinflammation
por: van Wijck, Rogier T. A., et al.
Publicado: (2022)

Curative Treatment of POMP-Related Autoinflammation and Immune Dysregulation (PRAID) by Hematopoietic Stem Cell Transplantation
por: Meinhardt, Andrea, et al.
Publicado: (2021)

Autoinflammation due to homozygous S208 MEFV mutation
por: Hong, Ying, et al.
Publicado: (2019)

Essential thrombocythemia: Busulphan revisited
por: Koduri, Prasad R.
Publicado: (2016)

Autoinflammation It Is!
por: Feist, Eugen
Publicado: (2021)

Efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis
por: Verstovsek, S, et al.
Publicado: (2016)

Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis
por: Tefferi, A, et al.
Publicado: (2017)

Ruxolitinib therapy and telomere length in myelofibrosis
por: Caocci, G, et al.
Publicado: (2016)

Autoinflammation and immunodeficiency
por: Frenkel, Joost
Publicado: (2014)

A Rare Case of Primary Myelofibrosis With a Solitary 1q Triplication
por: Kim, Jin-Hong, et al.
Publicado: (2020)

Re: Porphyria Cutanea Tarda in a Patient with Myelofibrosis
por: dos Santos, Vitorino M., et al.
Publicado: (2023)

Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis
por: Pardanani, A, et al.
Publicado: (2015)

Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis
por: Li, Bing, et al.
Publicado: (2017)

Liver function test abnormalities and their clinical relevance in primary myelofibrosis
por: Barraco, D, et al.
Publicado: (2017)

Micrornas in autoinflammation and autoimmunity
por: Apparailly, Florence
Publicado: (2014)

Gene hunting in autoinflammation
por: Standing, Ariane, et al.
Publicado: (2013)

The everchanging framework of autoinflammation
por: Manna, Raffaele, et al.
Publicado: (2021)

In vivo magnetic resonance imaging of a mouse model of myelofibrosis
por: Matsuura, S, et al.
Publicado: (2016)

Ruxolitinib changes the natural course of myelofibrosis and its transplant outcome
por: Jung, Chul Won
Publicado: (2013)

Clinical spectrum and therapeutic management of auto-immune myelofibrosis: a nation-wide study of 30 cases
por: Mertz, Philippe, et al.
Publicado: (2020)

Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation
por: Srour, Samer A., et al.
Publicado: (2019)

EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis
por: Prem, Shruti, et al.
Publicado: (2019)

Pathogenesis of Psoriasis: Focus on Autoinflammation
por: Marzano, Angelo Valerio, et al.
Publicado: (2018)

Imaging of Joints and Bones in Autoinflammation
por: Ziegeler, Katharina, et al.
Publicado: (2020)

Editorial: Autoinflammation of the inner ear
por: Nakanishi, Hiroshi, et al.
Publicado: (2022)

Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation
por: Chiusolo, Patrizia, et al.
Publicado: (2022)

Long-term treatment with pacritinib on a compassionate use basis in patients with advanced myelofibrosis
por: Harrison, Claire, et al.
Publicado: (2023)

Many questions raised by a question on JAK1/2 inhibitors in primary myelofibrosis
por: Raut, Lalit
Publicado: (2013)

Portal hypertension complicating myelofibrosis in a patient without portal or hepatic vein thrombosis
por: Qi, Xingshun, et al.
Publicado: (2014)

Megakaryoblastic leukemia presenting as pancytopenia and extensive myelofibrosis in a child diagnosed by myeloid markers and CD 31
por: Majhi, Urmila, et al.
Publicado: (2012)

Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients
por: Ding, Kai, et al.
Publicado: (2023)

Leukocytosis and presence of CALR mutation is associated with non-hepatosplenic extramedullary hematopoiesis in primary myelofibrosis
por: Barraco, D, et al.
Publicado: (2016)

SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML
por: Laborde, R R, et al.
Publicado: (2013)

G-CSF drives autoinflammation in APLAID
por: Mulazzani, Elisabeth, et al.
Publicado: (2023)

Adult Onset Still's Disease and Autoinflammation
por: Efthimiou, Petros, et al.
Publicado: (2012)

Genetic Hearing Loss Associated With Autoinflammation
por: Nakanishi, Hiroshi, et al.
Publicado: (2020)

Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations
por: Barraco, D, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kvmo7dtogeosqpaa5puqh7ke2r